Follow
Jared A. Leff
Jared A. Leff
Weill Cornell Medicine
Verified email at med.cornell.edu - Homepage
Title
Cited by
Cited by
Year
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially …
JR Morgan, BR Schackman, JA Leff, BP Linas, AY Walley
Journal of substance abuse treatment 85, 90-96, 2018
2922018
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
BP Linas, DM Barter, JA Leff, SA Assoumou, JA Salomon, MC Weinstein, ...
PloS one 9 (5), e97317, 2014
1472014
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection
BP Linas, DM Barter, JR Morgan, MT Pho, JA Leff, BR Schackman, ...
Annals of internal medicine 162 (9), 619-629, 2015
1252015
Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care
BR Schackman, JA Leff, D Polsky, BA Moore, DA Fiellin
Journal of general internal medicine 27, 669-676, 2012
1122012
Cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings
SA Assoumou, A Tasillo, JA Leff, BR Schackman, ML Drainoni, ...
Clinical Infectious Diseases 66 (3), 376-384, 2018
862018
Review of complications in a series of patients with known gastro-esophageal varices undergoing transesophageal echocardiography
BJ Spier, SJ Larue, TC Teelin, JA Leff, LR Swize, SH Borkan, ...
Journal of the American Society of Echocardiography 22 (4), 396-400, 2009
832009
Cost‐effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
BR Schackman, JA Leff, DM Barter, MA DiLorenzo, DJ Feaster, ...
Addiction 110 (1), 129-143, 2015
582015
Cost-effectiveness of buprenorphine–naloxone versus extended-release naltrexone to prevent opioid relapse
SM Murphy, KE McCollister, JA Leff, X Yang, PJ Jeng, JD Lee, EV Nunes, ...
Annals of internal medicine 170 (2), 90-98, 2019
572019
Cost‐effectiveness of blood donor screening for Babesia microti in endemic regions of the United States
MS Simon, JA Leff, A Pandya, M Cushing, BH Shaz, DP Calfee, ...
Transfusion 54 (3pt2), 889-899, 2014
452014
Optimising the care of patients with cirrhosis and gastrointestinal haemorrhage: a quality improvement study
EA Johnson, BJ Spier, JA Leff, MR Lucey, A Said
Alimentary pharmacology & therapeutics 34 (1), 76-82, 2011
442011
Monetary conversion factors for economic evaluations of substance use disorders
K McCollister, X Yang, B Sayed, MT French, JA Leff, BR Schackman
Journal of substance abuse treatment 81, 25-34, 2017
422017
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial
BR Schackman, LR Metsch, GN Colfax, JA Leff, A Wong, CA Scott, ...
Drug and alcohol dependence 128 (1-2), 90-97, 2013
382013
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs
BR Schackman, S Gutkind, JR Morgan, JA Leff, CN Behrends, ...
Drug and alcohol dependence 185, 411-420, 2018
312018
The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States
AA Eggman, DJ Feaster, JA Leff, MR Golden, PC Castellon, L Gooden, ...
Sexually transmitted diseases 41 (9), 545-550, 2014
252014
Costs of expanded rapid HIV testing in four emergency departments
BR Schackman, AA Eggman, JA Leff, M Braunlin, UR Felsen, L Fitzpatrick, ...
Public Health Reports 131 (1_suppl), 71-81, 2016
242016
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation
BR Schackman, JA Leff, M Botsko, DA Fiellin, FL Altice, PT Korthuis, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S76-S82, 2011
242011
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
BP Linas, DM Barter, JA Leff, M DiLorenzo, BR Schackman, ...
Aids 28 (3), 365-376, 2014
222014
HIV rapid testing in substance abuse treatment: Implementation following a clinical trial
LF Haynes, JE Korte, BE Holmes, L Gooden, T Matheson, DJ Feaster, ...
Evaluation and Program Planning 34 (4), 399-406, 2011
222011
Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics
NT Shen, JA Leff, Y Schneider, CV Crawford, A Maw, B Bosworth, ...
Open forum infectious diseases 4 (3), ofx148, 2017
212017
Economic evaluations of pharmacologic treatment for opioid use disorder: a systematic literature review
EN Onuoha, JA Leff, BR Schackman, KE McCollister, D Polsky, ...
Value in Health 24 (7), 1068-1083, 2021
192021
The system can't perform the operation now. Try again later.
Articles 1–20